Uptake of COVID-19 Vaccines among Pregnant Women: A Systematic Review and Meta-Analysis

Galanis, Petros; Vraka, Irène; Σίσκου, Όλγα; Konstantakopoulou, Olympia; Katsiroumpa, Aglaia; Kaitelidou, Daphne

doi:10.3390/vaccines10050766

Cited by 56 publications

(87 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We found that the primary reasons for refusing a second booster/new COVID-19 vaccine were worries about safety, effectiveness, and side effects; the low self-perceived risk of COVID-19 complications; and the belief that initial COVID-19 vaccine doses provide sufficient protection against the disease. These findings are confirmed by studies investigating the refusal of individuals to accept both the first COVID-19 booster dose [15,16,20,23,24] and the initial COVID-19 vaccine doses [29][30][31][32]. It is reasonable that individuals with a complete COVID-19 vaccine course are concerned about the need, safety, and effectiveness of another booster or a new vaccine and policy makers should consider these issues when they design education, communication, and policy-based interventions about COVID-19 vaccines [29,31].…”

Section: Discussionmentioning

confidence: 78%

Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece

et al. 2022

Self Cite

View full text Add to dashboard Cite

Given the concerns of waning immunity from the primary COVID-19 vaccines and the first booster dose, we conducted an online cross-sectional study in May 2022 to investigate willingness to receive a second COVID-19 booster dose or a new COVID-19 vaccine and its associated factors. Overall, 62% of the participants were willing to be vaccinated, 25.8% were unsure, and 12.3% were unwilling to be vaccinated. The main reasons against accepting a second COVID-19 booster dose/new COVID-19 vaccine were concerns about the side effects and the effectiveness and the opinion that further vaccination is unnecessary. Males, younger individuals, participants without a previous COVID-19 diagnosis, and those with good/very good self-perceived physical health were significantly more frequently willing to receive a second COVID-19 booster dose or a new COVID-19 vaccine. Additionally, increased fear of the COVID-19, increased trust in COVID-19 vaccinations, and decreased fear of a second booster dose or a new COVID-19 vaccine was associated with increased willingness. Our results show some hesitancy and unwillingness toward further COVID-19 vaccination and indicate that the fear of COVID-19 and trust in COVID-19 vaccination affects public opinion.

show abstract

Section: Discussionmentioning

confidence: 78%

Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…In a sample of pregnant women in Greece, we found that 58.6% of them were vaccinated against the COVID-19 during pregnancy. A recent meta-analysis found that the overall proportion of vaccinated pregnant women against the COVID-19 is 27.5% (Galanis, Vraka, Siskou, Konstantakopoulou, Katsiroumpa, & Kaitelidou, 2022b). Also, it is interesting to highlight the fact that the vaccination rate is much higher in Israel (43.3%) than in the USA (27.3%) and other countries (12.8%).…”

Section: Discussionmentioning

confidence: 99%

Psychosocial predictors of COVID-19 vaccine uptake among pregnant women: a cross-sectional study in Greece

Galanis

Vraka

Katsiroumpa

et al. 2022

Preprint

Self Cite

View full text Add to dashboard Cite

Background: Unvaccinated pregnant women with symptomatic COVID-19 have been found to have a higher risk of iatrogenic preterm births, intensive care unit admission, and invasive ventilation. Objective: To estimate the vaccination rate of pregnant women against the COVID-19 and to evaluate psychosocial factors associated with vaccine uptake among them. Methods: We conducted an anonymous cross-sectional study with a convenience sample in Greece from December 2021 to March 2022. We measured socio-demographic data of pregnant women, COVID-19-related vaccination status, worry about the side effects of COVID-19 vaccines, trust in COVID-19 vaccines, and COVID-19-related stress. Results: The study population included 812 pregnant women with a mean age of 31.6 years. Among the pregnant women, 58.6% had received a COVID-19 vaccine. The most important reasons that pregnant women were not vaccinated were doubts about the safety and effectiveness of COVID-19 vaccines (31.4%), fear that COVID-19 vaccines could be harmful to fetus (29.4%), and fear of adverse side effects of COVID-19 vaccines (29.4%). Increased danger and contamination fears, increased fears about economic consequences, and higher levels of trust in COVID-19 vaccines were related with COVID-19 vaccine uptake. On the other hand, increased compulsive checking and reassurance seeking and increased worry about the adverse side effects of COVID-19 vaccines reduced the likelihood of pregnant women being vaccinated against the COVID-19. Conclusions: An understanding of the psychosocial factors associated with COVID-19 vaccine uptake in pregnant women is paramount to persuade women to get vaccinated against the COVID-19. There is a need for targeted educational campaigns to increase knowledge about COVID-19 vaccines and reduce COVID-19 vaccine hesitancy in pregnancy.

show abstract

“… 16 In a recent systematic review and meta‐analysis the overall proportion of pregnant women vaccinated against COVID‐19 were 27.5%. 19 Predictors of COVID‐19 vaccination uptake were older age, ethnicity, race, trust in COVID‐19 vaccines and fear of COVID‐19 during pregnancy. 19 …”

Section: Vaccination During Pregnancy and Lactationmentioning

confidence: 99%

Action is needed to tackle the clinical, psychological and socioeconomic impact of perinatal COVID‐19

2022

View full text Add to dashboard Cite

The COVID‐19 pandemic has turned perinatal healthcare into a worldwide public health challenge. Although initial data did not demonstrate pregnancy as a more susceptible period to adverse outcomes of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection, an increasing number of reports now certify maternal illness as a high‐risk condition for the development of maternal–fetal complications. Despite the rarity of SARS‐CoV‐2 vertical transmission, severe maternal illness might induce adverse perinatal and neonatal outcomes. Additionally, perinatal COVID‐19 data may raise concerns about long‐term harmful consequences to the offspring in the framework of non‐communicable diseases. The World Health Organisation, as well as scientific literature, consider the protection of the maternal–fetal dyad against COVID‐19 as a critical issue and, therefore, strongly promote and encourage the vaccination of pregnant and lactating women. Furthermore, the pandemic has triggered an unprecedented recession, leading to historic levels of unemployment and deprivation, while health, societal, economic and gender inequities particularly affecting low‐income and middle‐income countries, have increased. This mini‐review provides an updated brief report on historical, clinical, psychological and socioeconomic aspects of the COVID‐19 pandemic based on 10 lectures presented at the 9th Maria‐Delivoria‐Papadopoulos Perinatal Symposium, held virtually on 19 March 2022.

show abstract

Uptake of COVID-19 Vaccines among Pregnant Women: A Systematic Review and Meta-Analysis

Cited by 56 publications

References 57 publications

Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece

Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece

Psychosocial predictors of COVID-19 vaccine uptake among pregnant women: a cross-sectional study in Greece

Action is needed to tackle the clinical, psychological and socioeconomic impact of perinatal COVID‐19

Contact Info

Product

Resources

About